What’s Wrong with Oklo’s Stock? A Realistic Look Today
Investing in nuclear energy can feel like riding a high-speed train. Oklo’s small modular reactors promise a greener ...
Which Total Market Fund To Hold In Retirement 2024
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articles
Hynix SanDisk Sink 7% as Micron Falls on CXMT IPO Buzz
Chinese memory-maker CXMT gears up for a high-profile $8.6 billion IPO, sparking renewed pressure on U.S. and Asian m...
Stock Market Live July 1 2026: Markets Cautious Ahead of Fed
U.S. equities drift modestly lower as traders await Federal Reserve cues and key data. This stock market live july br...
It’s Rough China’s Auto Market: Will Nio Weather the Storm?
China’s domestic auto market is feeling the squeeze even as exporters push ahead. Nio sits at a crossroads where poli...
Trump Discloses Expanding Financial Empire with Crypto Bets
Trump unveils an expanded financial footprint in a new annual disclosure, highlighting Apple stock, commemorative coi...
It’s Just Strategy: This Wave of Bitcoin Treasury Sales
Empery Digital has sold a sizable block of its bitcoin holdings, joining a broader trend among corporate treasuries m...
Strategy Moves Million BTC to Coinbase, Sparks Sell Speculation
Strategy moved 411.48 BTC worth more than $30 million to Coinbase Prime, prompting fresh debate about whether the sta...
Batteries Beat 500: BATT Outpaces SPY in Broad Rally
Battery-focused BATT has surged past the SPY, led by a year of strong gains in battery metals and EV supply chains.
Where Will Nuscale Power Be in 10 Years? A Practical Look
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
Why Viking Therapeutics Stock More Is Turning Heads Today
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Surprise! This Giant That's Rising Now Is Second Cheapest
A mega-cap AI stock has defied the hype by turning into the unexpected bargain of the Magnificent Seven. Learn what t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status